BSV, Bharat Serums and Vaccines Ltd, has created innovative biologic products internally, showcasing their impressive research and development skills. They have a diverse collection of branded products in women's health, fertility, critical care...
Oblique Therapeutics, a top biotech company focused on creating new drugs, has partnered with Eli Lilly and Company (Lilly) to use the AbiProt technology in developing antibodies for a valuable target. This collaboration is designed to speed up...
Angelini Pharma, a division of Angelini Industries, and Cureverse Inc., a startup company, revealed they have signed a unique worldwide option contract to develop and market Cureverse's groundbreaking brain health asset CV-01. According to the...
The anti-diabetes market has tripled to almost Rs 17,000 crore, and the cardiac market has more than doubled to nearly Rs 30,000 crore from its 2014 levels of Rs 5,000 crore and Rs 10,000 crore, respectively. Sheetal Sapale, vice president of...
Boston Scientific Corporation, a leading global medical technology company, stated it got approval from the US FDA for the Farawave NAV Ablation Catheter and FDA 510(k) clearance for the Faraview Software, both used in treating paroxysmal atrial...
Indian companies supply 40% of the world's generic medicines, showcasing India's important role in global healthcare. Dr. Jitendra Kumar, Managing Director of BIRAC, stated that the biotechnology industry in the country is experiencing impressive...
TuHURA Biosciences, a company in phase 3 of registering immune-oncology, is creating new technologies to tackle resistance to cancer immunotherapy. They have finished the merger with Kintara Therapeutics, Inc. and are now called TuHURA Biosciences...
Sanofi and Orano Med, which is a part of the Orano Group and specializes in targeted alphatherapies for cancer treatment, have agreed to collaborate in order to advance the development of advanced radioligand treatments for rare cancers. Sanofi...
Lindy Biosciences, a protein therapeutic formulations firm, has announced a partnership with Novartis Pharmaceuticals to focus more on evolving drugs from Novartis to subcutaneous injections by using their micro classification suspension...
USV Pvt. Ltd. has launched OnArni, a combination of Sacubitril and Valsartan, for treating heart failure, available at an affordable price of Rs. $8 is the cost for each tablet of 50mg. This affordable solution helps tackle the increasing...
, CDSCO.jpg)
